Tryptase inhibitors: a patent review

Area of Science:

• Biochemistry
• Pharmacology
• Drug Discovery

Background:

• Tryptase, a key enzyme in mast cell degranulation, contributes to allergic inflammation, cardiovascular diseases, fibrosis, and tumors.
• Targeting tryptase offers a novel therapeutic approach for various diseases.

Purpose of the Study:

• To review the historical development of tryptase inhibitors.
• To describe various tryptase inhibitors, their structures, and clinical relevance.
• To highlight future directions in tryptase inhibitor drug development.

Main Methods:

• Literature review of tryptase inhibitors.
• Analysis of inhibitor structures and their biological importance.
• Discussion of clinical studies and drug development progress.

Main Results:

• Early tryptase inhibitors exhibited low specificity and poor bioavailability.
• Structural modifications, including N-substitution and amide bond introduction, enhance inhibitor selectivity and potency.
• Tryptase is a significant research focus for disease exploration.

Conclusions:

• Developing novel, specific tryptase inhibitors is crucial for future clinical studies.
• Optimized tryptase inhibitors hold significant therapeutic potential for tryptase-related diseases.
• Continued research into tryptase inhibitors is warranted given their emerging importance.